RHOADS ANN D 4

What Happened

• Ann D. Rhoads, a director of QuidelOrtho Corporation (QDEL), had restricted stock units (RSUs) released and converted into 1,407 shares of common stock (1,173 + 234) on May 22, 2026. The transactions are reported as awards/acquisitions (code A) and conversions/exercises of derivatives (code M) at $0.00 per share — i.e., no cash payment was required. These RSUs were previously granted and reported; the current filing reflects their scheduled release under a deferred compensation arrangement.

Key Details

• Transaction date: May 22, 2026; Form 4 filed May 27, 2026 (filing timeliness not indicated in the filing).
• Transaction types and amounts: 1,173 RSUs released and converted; 234 RSUs released and converted — total 1,407 shares acquired at $0.00 per share.
• Consideration: $0.00 reported (conversion of RSUs into shares).
• Footnotes: (1) release of previously reported RSUs; (2) each RSU equals one share of common stock; (3) release was deferred per QuidelOrtho’s deferred compensation program for non-employee directors and occurred according to the elected deferral schedule.
• Shares owned after the transaction: not specified in this Form 4.

Context

• This was a scheduled RSU release/conversion (deferred compensation payout), not an open-market purchase or sale. For retail investors, such releases are generally routine compensation events and do not alone indicate the insider’s short-term market view. The filing shows conversion of derivative awards (RSUs) into shares rather than a cash exercise or an immediate sale.